Skip to content

The effect of Anethum graveolens supplementation on some blood biochemical parameters in type 2 Diabetes Patients

The effect of Anethum graveolens supplementation on some blood biochemical parameters in type 2 Diabetes Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201112312017N6
Enrollment
60
Registered
2012-01-10
Start date
2012-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type2. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention group: daily 3 pill of containing 1g powder of Anethum herb for 60 day. Intervention 2: Placebo group: 3 pill containing 1g powder of isomalt for 60 day.
Treatment - Drugs
Intervention group: daily 3 pill of containing 1g powder of Anethum herb for 60 day
Placebo group: 3 pill containing 1g powder of isomalt for 60 day

Sponsors

Vice-chancellor for research of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 18-65 years; proven diagnosis for diabetes mellitus; absence of antioxidants supplementation in previous months or in the study and absence of special diet. Exclusion criteria: history of impaired immune system; alcohol use and depression.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Lipid profiles (TC, TG, LDL-C, HDL-C). Timepoint: Baseline and at the end of intervention. Method of measurement: Enzymatic methods for TC,TG and HDL-C For LDL-C : Freidwald’s formula: LDL-C = TC- HDL-C - (TG/5).;Inflammation markers (hs-CRP ? TNF-a?IL-6). Timepoint: Baseline and at the end of intervention. Method of measurement: ELISA.;Blood glucose. Timepoint: Baseline and at the end of intervention. Method of measurement: Enzymatic method.

Secondary

MeasureTime frame
Serum Antioxidant. Timepoint: Baseline and at the end of intervention. Method of measurement: enzymatic method.;Nutritional status. Timepoint: Baseline and at the end of intervention. Method of measurement: Dietary record and food frequency questionnaire.;Anthropometric measurements. Timepoint: Baseline and at the end of intervention. Method of measurement: Analogue scale and meter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLaleh Payahoo

Tabriz university of medical science

llllpayahoo44@gmail.com+98 41 1335 2295

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026